
Amber D. Steele
Examiner (ID: 2430, Phone: (571)272-5538 , Office: P/1676 )
| Most Active Art Unit | 1658 |
| Art Unit(s) | 1654, 1639, 1658, 1676 |
| Total Applications | 1302 |
| Issued Applications | 628 |
| Pending Applications | 166 |
| Abandoned Applications | 538 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 13957887
[patent_doc_number] => 20190055287
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-02-21
[patent_title] => POLYPEPTIDE, DNA MOLECULE ENCODING THE POLYPEPTIDE, VECTOR, PREPARATION METHOD AND USE
[patent_app_type] => utility
[patent_app_number] => 16/178499
[patent_app_country] => US
[patent_app_date] => 2018-11-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14570
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16178499
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/178499 | Polypeptide, DNA molecule encoding the polypeptide, vector, preparation method and use | Oct 31, 2018 | Issued |
Array
(
[id] => 17905511
[patent_doc_number] => 11459355
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-10-04
[patent_title] => Peptides having octopus octopressin activity and use thereof
[patent_app_type] => utility
[patent_app_number] => 17/058528
[patent_app_country] => US
[patent_app_date] => 2018-10-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 7
[patent_no_of_words] => 5931
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17058528
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/058528 | Peptides having octopus octopressin activity and use thereof | Oct 23, 2018 | Issued |
Array
(
[id] => 16375122
[patent_doc_number] => 20200323964
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-15
[patent_title] => PEPTIDES AND NANOPARTICLES FOR INTRACELLULAR DELIVERY OF MRNA
[patent_app_type] => utility
[patent_app_number] => 16/756442
[patent_app_country] => US
[patent_app_date] => 2018-10-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 124086
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16756442
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/756442 | PEPTIDES AND NANOPARTICLES FOR INTRACELLULAR DELIVERY OF MRNA | Oct 14, 2018 | Abandoned |
Array
(
[id] => 14132335
[patent_doc_number] => 20190100557
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-04-04
[patent_title] => PROTRANSDUZIN B, A GENE TRANSFER ENHANCER
[patent_app_type] => utility
[patent_app_number] => 16/159900
[patent_app_country] => US
[patent_app_date] => 2018-10-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1978
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16159900
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/159900 | PROTRANSDUZIN B, A GENE TRANSFER ENHANCER | Oct 14, 2018 | Abandoned |
Array
(
[id] => 14072325
[patent_doc_number] => 20190085050
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-03-21
[patent_title] => POLYPEPTIDES AND USES THEREOF FOR REDUCING CD95-MEDIATED CELL MOTILITY
[patent_app_type] => utility
[patent_app_number] => 16/156521
[patent_app_country] => US
[patent_app_date] => 2018-10-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21108
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16156521
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/156521 | Polypeptides and uses thereof for reducing CD95-mediated cell motility | Oct 9, 2018 | Issued |
Array
(
[id] => 14624585
[patent_doc_number] => 20190225660
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-07-25
[patent_title] => METHOD OF TREATING AND PREVENTING OCULAR ANGIOGENESIS
[patent_app_type] => utility
[patent_app_number] => 16/150020
[patent_app_country] => US
[patent_app_date] => 2018-10-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10514
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16150020
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/150020 | METHOD OF TREATING AND PREVENTING OCULAR ANGIOGENESIS | Oct 1, 2018 | Abandoned |
Array
(
[id] => 15711181
[patent_doc_number] => 20200102356
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-04-02
[patent_title] => Compositions and Methods for the Treatment of Huanglongbing (HLB) aka Citrus Greening in Citrus Plants
[patent_app_type] => utility
[patent_app_number] => 16/148848
[patent_app_country] => US
[patent_app_date] => 2018-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21998
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -31
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16148848
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/148848 | Compositions and Methods for the Treatment of Huanglongbing (HLB) aka Citrus Greening in Citrus Plants | Sep 30, 2018 | Pending |
Array
(
[id] => 13826557
[patent_doc_number] => 20190016763
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-01-17
[patent_title] => Fibroin-Like Protein Variant and Cell Culture Method
[patent_app_type] => utility
[patent_app_number] => 16/144562
[patent_app_country] => US
[patent_app_date] => 2018-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26544
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 167
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16144562
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/144562 | Fibroin-Like Protein Variant and Cell Culture Method | Sep 26, 2018 | Abandoned |
Array
(
[id] => 17467690
[patent_doc_number] => 11274158
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-03-15
[patent_title] => Methods and compositions for treating inflammatory or autoimmune diseases or conditions using calcitonin receptor activators
[patent_app_type] => utility
[patent_app_number] => 16/140224
[patent_app_country] => US
[patent_app_date] => 2018-09-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 44073
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16140224
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/140224 | Methods and compositions for treating inflammatory or autoimmune diseases or conditions using calcitonin receptor activators | Sep 23, 2018 | Issued |
Array
(
[id] => 19258052
[patent_doc_number] => 12018096
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-06-25
[patent_title] => Potent peptide inhibitors of protein aggregation
[patent_app_type] => utility
[patent_app_number] => 16/647149
[patent_app_country] => US
[patent_app_date] => 2018-09-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 3774
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16647149
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/647149 | Potent peptide inhibitors of protein aggregation | Sep 19, 2018 | Issued |
Array
(
[id] => 16253515
[patent_doc_number] => 20200262889
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-20
[patent_title] => SUCCINATE-BINDING POLYPEPTIDES AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/647945
[patent_app_country] => US
[patent_app_date] => 2018-09-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19624
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16647945
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/647945 | Succinate-binding polypeptides and use thereof | Sep 17, 2018 | Issued |
Array
(
[id] => 16296286
[patent_doc_number] => 20200282009
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-10
[patent_title] => METHODS OF TREATING DISEASES ASSOCIATED WITH VASCULAR SMOOTH MUSCLE CELL PROLIFERATION
[patent_app_type] => utility
[patent_app_number] => 16/646594
[patent_app_country] => US
[patent_app_date] => 2018-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11550
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16646594
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/646594 | METHODS OF TREATING DISEASES ASSOCIATED WITH VASCULAR SMOOTH MUSCLE CELL PROLIFERATION | Sep 11, 2018 | Abandoned |
Array
(
[id] => 14258827
[patent_doc_number] => 10278957
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-05-07
[patent_title] => Opioid agonist peptides and uses thereof
[patent_app_type] => utility
[patent_app_number] => 16/128352
[patent_app_country] => US
[patent_app_date] => 2018-09-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 7
[patent_no_of_words] => 28563
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 127
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16128352
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/128352 | Opioid agonist peptides and uses thereof | Sep 10, 2018 | Issued |
Array
(
[id] => 13733185
[patent_doc_number] => 20180371060
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-12-27
[patent_title] => MODIFIED PIGMENT EPITHELIUM-DERIVED FACTOR (PEDF) PEPTIDES AND USES THEREOF FOR TREATING NEOVASCULAR DISEASES, INFLAMMATORY DISEASES, CANCER, AND FOR CYTOPROTECTION
[patent_app_type] => utility
[patent_app_number] => 16/123863
[patent_app_country] => US
[patent_app_date] => 2018-09-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18904
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 443
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16123863
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/123863 | Modified pigment epithelium-derived factor (PEDF) peptides and uses thereof for treating neovascular diseases, inflammatory diseases, cancer, and for cytoprotection | Sep 5, 2018 | Issued |
Array
(
[id] => 14277203
[patent_doc_number] => 20190135886
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-09
[patent_title] => GIP-GLP-1 DUAL AGONIST COMPOUNDS AND METHODS
[patent_app_type] => utility
[patent_app_number] => 16/121745
[patent_app_country] => US
[patent_app_date] => 2018-09-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17587
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16121745
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/121745 | GIP-GLP-1 DUAL AGONIST COMPOUNDS AND METHODS | Sep 4, 2018 | Abandoned |
Array
(
[id] => 13733961
[patent_doc_number] => 20180371448
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-12-27
[patent_title] => MODIFICATIONS OF PEPTIDE COMPOSITIONS TO INCREASE STABILITY AND DELIVERY EFFICIENCY
[patent_app_type] => utility
[patent_app_number] => 16/120156
[patent_app_country] => US
[patent_app_date] => 2018-08-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5813
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -1
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16120156
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/120156 | MODIFICATIONS OF PEPTIDE COMPOSITIONS TO INCREASE STABILITY AND DELIVERY EFFICIENCY | Aug 30, 2018 | Abandoned |
Array
(
[id] => 16437102
[patent_doc_number] => 20200354428
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2020-11-12
[patent_title] => ANALOGUES OF PARATHYROID HORMONE (1-34) THAT FUNCTION AS AGONISTS OF THE PARATHYROID HORMONE RECEPTOR-1 AND DISPLAY MODIFIED ACTIVITY PROFILES
[patent_app_type] => utility
[patent_app_number] => 16/109114
[patent_app_country] => US
[patent_app_date] => 2018-08-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11012
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 84
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16109114
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/109114 | ANALOGUES OF PARATHYROID HORMONE (1-34) THAT FUNCTION AS AGONISTS OF THE PARATHYROID HORMONE RECEPTOR-1 AND DISPLAY MODIFIED ACTIVITY PROFILES | Aug 21, 2018 | Abandoned |
Array
(
[id] => 16437102
[patent_doc_number] => 20200354428
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2020-11-12
[patent_title] => ANALOGUES OF PARATHYROID HORMONE (1-34) THAT FUNCTION AS AGONISTS OF THE PARATHYROID HORMONE RECEPTOR-1 AND DISPLAY MODIFIED ACTIVITY PROFILES
[patent_app_type] => utility
[patent_app_number] => 16/109114
[patent_app_country] => US
[patent_app_date] => 2018-08-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11012
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 84
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16109114
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/109114 | ANALOGUES OF PARATHYROID HORMONE (1-34) THAT FUNCTION AS AGONISTS OF THE PARATHYROID HORMONE RECEPTOR-1 AND DISPLAY MODIFIED ACTIVITY PROFILES | Aug 21, 2018 | Abandoned |
Array
(
[id] => 17133629
[patent_doc_number] => 11135163
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-10-05
[patent_title] => Peptide hydrogel properties and its applications
[patent_app_type] => utility
[patent_app_number] => 16/109119
[patent_app_country] => US
[patent_app_date] => 2018-08-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 48
[patent_no_of_words] => 18924
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 77
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16109119
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/109119 | Peptide hydrogel properties and its applications | Aug 21, 2018 | Issued |
Array
(
[id] => 17385587
[patent_doc_number] => 20220033439
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-03
[patent_title] => PEPTIDE TARGETING MYCOBACTERIUM TUBERCULOSIS TOXIN-ANTITOXIN SYSTEM AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/632867
[patent_app_country] => US
[patent_app_date] => 2018-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6670
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16632867
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/632867 | PEPTIDE TARGETING MYCOBACTERIUM TUBERCULOSIS TOXIN-ANTITOXIN SYSTEM AND USE THEREOF | Jul 30, 2018 | Abandoned |